AN2 Therapeutics, Inc. Common Stock (ANTX) is a publicly traded Healthcare sector company. As of July 21, 2026, ANTX trades at $4.96 with a market cap of $168.56M and a P/E ratio of -2.84. ANTX moved +2.71% today. Year to date, ANTX is +344.44%; over the trailing twelve months it is +336.36%. Its 52-week range spans $1.00 to $6.91. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces ANTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ANTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $4.96 |
| Market Cap | $168.56M |
| P/E Ratio | -2.84 |
| EPS | $-1.72 |
| Dividend Yield | 0.66% |
| 52-Week High | $6.91 |
| 52-Week Low | $1.00 |
| Volume | 69.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-51.32M |
| Gross Margin | 0.00% |
1 analysts cover ANTX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.